Prestige Consumer Healthcare Reports Fiscal 2026 Results, Acquires LaCorium Health
PBH is trading near its 52-week low of $49.28 (5.1% above the low).
Summary
Prestige Consumer Healthcare Inc. has announced its fiscal 2026 results and simultaneously disclosed the acquisition of LaCorium Health. This news provides a comprehensive update on the company's financial performance for the full fiscal year and signals a strategic expansion through M&A. While specific financial details for the results (e.g., revenue, EPS, guidance) and the acquisition terms (e.g., deal value, financing) are not provided in the headline, both events are material for a company of this size. Traders will be closely watching for the full details of the earnings report and the strategic implications of the LaCorium Health acquisition, which could impact future growth and profitability.
At the time of this announcement, PBH was trading at $51.81 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $49.28 to $89.37. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.